Threshold Reports Positive Phase II Results For Glufosfamide For Advanced Pancreatic Cancer

Company is exploring next steps for the oncologic in the pancreatic cancer setting while trials are ongoing for other cancers.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet